Mitsubishi Corporation has reserved and pre-purchased capacity on Starlab's commercial space station, becoming a foundational customer and joining its board through representative Issei Shinohara. The expanded partnership secures payload rights for drug discovery, nano-medicine, new material development and next-generation semiconductor manufacturing while boosting Mitsubishi's equity stake in the venture.